• Non ci sono risultati.

EXPERIMENTAL SECTION

N/A
N/A
Protected

Academic year: 2021

Condividi "EXPERIMENTAL SECTION"

Copied!
8
0
0

Testo completo

(1)

EXPERIMENTAL

SECTION

(2)
(3)

55

Routine nuclear magnetic resonance spectra were recorded in

DMSO-d6 solution on a Varian Gemini 200 spectrometer operating at 200

MHz. Evaporation was performed in vacuo (rotary evaporator).

Analytical TLC was carried out on Merck 0.2 mm precoated silica gel

aluminum sheets (60 F-254). Silica gel 60 (230-400 mesh) was used

for column chromatography. Elemental analyses were performed by

our analytical laboratory and agreed with theoretical values to within

±0.4%.

2-hydrazinyl-1H-benzo[d]imidazole

(

62

),

(Z)-2-(2-(1H-benzo[d]imidazol-2-yl)hydrazono)-2-phenylacetic acid

(

63

)

and

3-phenyl[1,2,4]Triazino[4,3-a]benzimidazol-4(10H)-one

(

64

)

were prepared in accordance with a reported procedure. 100,101

2-hydrazinyl-1H-benzo[d]imidazole

62

.

Yield: 60%; mp= 148-151 °C (lit. ref. n. 101 mp=146-147 °C).

(Z)-2-(2-(1H-benzo[d]imidazol-2-yl)hydrazono)-2-phenylacetic acid

63

.

Yield: 83%; mp = 240-243 °C (lit. ref. n. 100 mp = 247-250 °C)

3-phenyl[1,2,4]Triazino[4,3-a]benzimidazol-4(10H)-one

64

.

Yield: 91%; mp = >300°C (lit. ref. n. 100 mp = > 300 °C)

Yield, melting point and spectral data of compounds 62, 63 and 64 were reported in literature. 100,101

(4)

56

General procedure for:

N10

-[(ethoxycarbonyl)methyl]-3-phenyl[1,2,4]Triazino[4,3-a]benzimidazol-[4(10H)-one] (65) and

N1

-[(ethoxycarbonyl)methyl]-3-phenyl[1,2,4]Triazino[4,3-a]benzimidazol-[4(10H)-one (66).

Sodium hydride (3 mmol) was added in small portions to a solution of 3-phenyl[1,2,4]Triazino[4,3-a]benzimidazol-4(10H)-one (64) (3 mmol) in 10 mL of anhydrous DMF, cooled at 0 °C. After the development of H2 (about 1h),

Ethyl bromo acetate (3 mmol), dissolved in 2 mL of the same solvent, was added dropwise. The reaction mixture was maintained under stirring at room temperature for 24h (TLC analysis). The solution was dripped into ice and once the ice dissolved, the formed precipitate was collected by filtration (TLC analysis) and purified by flash chromatography (Toluene/Acetonitrile= 9/1 as eluent). We obtained two regioisomers. Yield: 65: 70%; 66: 30%. N10 -[(ethoxycarbonyl)methyl]-3-phenyl[1,2,4]Triazino[4,3-a]benzimidazol-[4(10H)-one] 65. Yield: 70%; 1H-NMR (DMSO-d6, ppm): 1.23 (t, 3H, CH3,

J=7,1 Hz); 4.17-4.27 (m, 2H, CH2); 5.37 (s, 2H, CH2); 7.42-7.59 (m, 5H, ArH);

7.75 (d, 1H, ArH, J=7,8 Hz); 8.03-8.06 (m, 2H, ArH); 8.38 (d, 1H, ArH, J=7,8 Hz).

N1 -[(ethoxycarbonyl)methyl]-3-phenyl[1,2,4]Triazino[4,3-a]benzimidazol-[4(10H)-one 66. Yield: 30%; 1H-NMR (DMSO-d6, ppm): 1.22 (t, 3H, CH3,

J=6,9 Hz); 4.18-4.25 (m, 2H, CH2); 5.32 (s, 2H, CH2); 7.48-7.53 (m, 4H, ArH);

(5)

57

General Procedure for:

N10 -[BOC-(amminobutylcarbamoyl)methyl]-3-phenyl[1,2,4]Triazino[4,3-a]benzimidazol-[4(10H)-one] (67), N10 -[BOC-(amminohexylcarbamoyl)methyl]-3-phenyl[1,2,4]Triazino[4,3-a]benzimidazol-[4(10H)-one] (68), N1 -[BOC-(amminobutylcarbamoyl)methyl]-3-phenyl[1,2,4]Triazino[4,3-a]benzimidazol-[4(10H)-one] (73) and N1 -[BOC-(amminohexylcarbamoyl)methyl]-3-phenyl[1,2,4]Triazino[4,3-a]benzimidazol-[4(10H)-one] (74).

Compound 65 or 66 (0,6 mmol) was heated at 80 °C in a Pyrex capped tube with N-Boc-1,4-butanediamine or N-Boc-1,6-hexanediamine (1,2 mmol), for 3h (TLC analysis). The precipitate was dissolved with CH2Cl2 and washed with

HCl 10%. After drying with MgSO4, the dichloromethane solution was

evaporated under reduced pressure, yielding the crude product that was purified by flash-chromatography (AcOEt/Hexane=5/5).

N10

-[BOC-(amminobutylcarbamoyl)methyl]-3-phenyl[1,2,4]Triazino[4,3-a]benzimidazol-[4(10H)-one] 67. Yield: 70%; 1H-NMR (DMSO-d6, ppm):

1.23-1.51 (m, 13H, 3CH3, 2CH2); 2.85-3.09 (m, 4H, 2CH2); 5.09 (s, 2H, CH2);

6.77 (m, 1H, NH, exch D2O); 7.41-7.58 (m, 5H, ArH); 7.74 (d, 1H, J=8 Hz,

ArH); 8.02-8.05 (m, 2H, ArH); 8.16-8.18 (m, 1H, NH, exch D2O); 8.39 (d, 1H,

J=8Hz, ArH).

N10

-[BOC-(amminohexylcarbamoyl)methyl]-3-phenyl[1,2,4]Triazino[4,3-a]benzimidazol-[4(10H)-one] 68. Yield: 74%; 1H-NMR (DMSO-d6, ppm):

1.24-1.37 (m, 17H, 4CH2, 3CH3); 2.56-2.59 (m, 4H, 2CH2); 5.10 (s, 2H, CH2);

6.75-6.76 (m, 1H, NH, exch D2O); 7.37-7.44 (m, 1H, ArH); 7.46-7.58 (m, 4H,

ArH); 7.74 (d, 1H, ArH, J=8 Hz); 8.03-8.05 (m, 2H, ArH); 8.15 (t, NH, exch D2O, J=5.6 Hz); 8.40 (d, 1H, ArH, J=6 Hz).

N1

-[BOC-(amminobutylcarbamoyl)methyl]-3-phenyl[1,2,4]Triazino[4,3-a]benzimidazol-[4(10H)-one] 73. Yield: 79%; 1H-NMR (DMSO-d6, ppm):

1.22-1.34 (m, 13H, 2CH2, 3CH3); 2.89-3.07 (m, 4H, 2CH2); 5.07 (s, 2H, CH2);

6.76-6.79 (m, 1H, NH, exch D2O); 7.46-7.82 (m, 5H, ArH); 8.14-8.20 (m, 2H,

(6)

58 N1

-[BOC-(amminohexylcarbamoyl)methyl]-3-phenyl[1,2,4]Triazino[4,3-a]benzimidazol-[4(10H)-one] 74. Yield: 81%; 1H-NMR (DMSO-d6, ppm):

1.18-1.30 (m, 17H, 4 CH2 , 3CH3); 2.80-3.06 (m, 4H, 2CH2); 5.03 (s, 2H, CH2);

6.70-6.74 (m, 1H, NH, exch D20); 7.45-7.73 (m, 5H, ArH); 8.15-8.19 (m, 2H, ArH);

8.24-8.27 (m, 1H, NH, exch D2O); 8.50 (d, 2H, ArH, J=7,8 Hz).

General Procedure for:

N10 -[(amminobutylcarbomoyl)methyl]-3-phenyl[1,2,4]Triazino[4,3-a]benzimidazol-[4(10H)-one] (69), N10 -[(amminohexylcarbomoyl)methyl]-3-phenyl[1,2,4]Triazino[4,3-a]benzimidazol-[4(10H)-one] (70), N1 -[(amminobutylcarbomoyl)methyl]-3-phenyl[1,2,4]Triazino[4,3-a]benzimidazol-[4(10H)-one] (75) and N1 -[(amminohexylcarbomoyl)methyl]-3-phenyl[1,2,4]Triazino[4,3-a]benzimidazol-[4(10H)-one] (76).

Trifluoroacetic acid (2,1 mmol) was added to a stirred solution of derivatives

67

,

68

,

73

or

74 (0,21 mmol) dissolved in 10 mL of CH2Cl2. The reaction

mixture was stirred at room temperature until the disappearance of the starting material (8h, TLC analysis). The dichloromethane was evaporated under reduced pressure and then the product obtained was diluted with ice. Once the ice dissolved, the solution was treated with saturated NaOH aqueous solution to pH=10 and extracted with CH2Cl2. After drying with

MgSO4,the organic solution was evaporated under reduced pressure, yielding

the crude product.

N10

-[(amminobutylcarbomoyl)methyl]-3-phenyl[1,2,4]Triazino[4,3-a]benzimidazol-[4(10H)-one] 69. Yield: 87%; 1H-NMR (DMSO-d6, ppm):

1.21-1.50 (m, 6H, 5CH2); 3.07 (q, 2H, CH2, J=8,8 Hz); 5.07 (s, 2H, CH2);

7.39-7.57 (m, 5H, ArH); 7.73 (d, 1H, ArH, J=8 Hz); 8.01 (d, 2H, ArH, J=4.8 Hz); 8.18 (m, 1H, NH, exch D2O); 8.37(d, 1H, ArH, J=8,2 Hz).

N10

-[(amminohexylcarbomoyl)methyl]-3-phenyl[1,2,4]Triazino[4,3-a]benzimidazol-[4(10H)-one] 70. Yield: 83%; 1H-NMR (DMSO-d6, ppm):

(7)

7.40-59 7.55 (m, 4H, ArH); 7.72 (d, 1H, ArH, J=8,4 Hz); 7.99-8.01 (m, 2H, ArH); 8.14-8.18 (m, 1H, NH, exch D2O); 8.37-8.40 (m, 2H, ArH).

N1

-[(amminobutylcarbomoyl)methyl]-3-phenyl[1,2,4]Triazino[4,3-a]benzimidazol-[4(10H)-one] 75. Yield: 88%; 1H-NMR (DMSO-d6, ppm):

1.32-1.46 (m, 6H, 3CH2); 3.10 (q, 2H, CH2, J=9,7Hz); 5.10 (s, 2H, CH2);

7.47-7.54 (m, 4H, ArH); 7.68 (m, 1H, ArH); 7.73 (d, 1H, ArH, J=8Hz); 8.19-8.21 (m, 2H, ArH); 8.33 (t, 1H, J=6 Hz, NH, exch D2O); 8.53 (d, 1H, ArH, J=8Hz).

N1

-[(amminohexylcarbomoyl)methyl]-3-phenyl[1,2,4]Triazino[4,3-a]benzimidazol-[4(10H)-one] 76. Yield: 84%; 1H-NMR (DMSO-d6, ppm):

1.24-1.52 (m, 10H, 5CH2); 3.08 (q, 2H, CH2, J=9,8 Hz); 5.08 (s, 2H, CH2);

7.46-7.53 (m, 4H, ArH); 7.63-7.73 (m, 2H, ArH); 8.19 (d, 2H, ArH, J=8 Hz); 8.28 (t, 1H, NH, J=6,8 Hz, exch D2O); 8.52 (d, 1H, ArH, J=8 Hz).

General Procedure for:

N10 -((4-(4-nitrobenzo[c][1,2,5]oxadiazol-7- ylamino)hexylcarbamoyl)methyl)-3-phenyl[1,2,4]Triazino[4,3-a]benzimidazol-[4(10H)-one] (71), N10 -((6-(4-nitrobenzo[c][1,2,5]oxadiazol-7- ylamino)butylcarbamoyl)methyl)-3-phenyl[1,2,4]Triazino[4,3-a]benzimidazol-[4(10H)-one] (72), N1 -((4-(4-nitrobenzo[c][1,2,5]oxadiazol-7- ylamino)butylcarbamoyl)methyl)-3-phenyl[1,2,4]Triazino[4,3-a]benzimidazol-[4(10H)-one] (77) and N1 -((6-(4-nitrobenzo[c][1,2,5]oxadiazol-7- ylamino)hexylcarbamoyl)methyl)-3-phenyl[1,2,4]Triazino[4,3-a]benzimidazol-[4(10H)-one] (78).

4-Chloro-7-nitrobenzofurazan (0,28 mmol) dissolved in 1 mL of anhydrous DMF was added dropwise to a stirred solution of derivatives 69, 70, 75 or

76 (0,28 mmol), in 10 mL of the same solvent, cooled at 0 °C, followed by addition of a solution of Triethylamine (0,30 mmol). The reaction mixture was allowed under stirring for 48h at room temperature (TLC analysis). The organic solvent was eliminated under vacuum, the product obtained was diluted with ice and the solution was extracted with CH2Cl2. After drying

(8)

60 pressure, yielding the crude product that was purified by flash-chromatography (AcOEt=10).

N10 -((4-(4-nitrobenzo[c][1,2,5]oxadiazol-7-ylamino)hexylcarbamoyl)methyl)-3-phenyl[1,2,4]Triazino[4,3-a]benzimidazol-[4(10H)-one] 71. Yield: 51%;

1H-NMR (DMSO-d6, ppm): 1.54-1.58 (m, 2H, CH2); 1.68-1.72 (m, 2H, CH2);

3.20-3.21 (m, 2H, CH2); 3.42-3.45 (m, 2H. CH2); 5.11 (s, 2H, CH2); 6.32-6.34 (m,

1H, ArH); 7.32-7.36 (m, 1H, ArH); 7.45-7.49 (m, 4H, ArH); 7.65-7.66 (m, 1H, ArH); 8.03-8.05 (m, 2H, ArH); 8.26 (t, 1H, NH, J=5,4 Hz, exch D2O);

8.32-8.36 (m, 2H, ArH); 9.46-9.48 (m, 1H, NH, exch D2O).

N10 -((6-(4-nitrobenzo[c][1,2,5]oxadiazol-7-ylamino)butylcarbamoyl)methyl)-3-phenyl[1,2,4]Triazino[4,3-a]benzimidazol-[4(10H)-one] 72. Yield: 48%;

1H-NMR (DMSO-d6, ppm): 1.30-1.42 (m, 6H, 3CH2); 1.57-1.60 (m, 2H, CH2); 3.12

(q, 2H, CH2, J=9Hz); 3.36-3.39 (m, 2H, CH2); 5.08 (s, 2H, CH2); 6.26-6.29 (m,

1H, ArH); 7.38 (t, 1H, ArH, J=7,9Hz); 7.48-7.54 (m, 4H, ArH); 7.72 (d, 1H, ArH, J=7,8Hz); 8.03-8.05 (m, 2H, ArH); 8.18 (t, 1H, NH, J=6Hz, exch D2O);

8.36 (d, 1H, ArH, J=8,3Hz); 8.45 (d, 1H, ArH, J=8Hz); 9.46-9.55 (m, 1H, NH, exch D2O). N1 -((4-(4-nitrobenzo[c][1,2,5]oxadiazol-7-ylamino)butylcarbamoyl)methyl)-3-phenyl[1,2,4]Triazino[4,3-a]benzimidazol-[4(10H)-one] 77. Yield: 54%; 1H-NMR (DMSO-d6, ppm): 1.49-1.54 (m, 4H, 2CH2); 1.55-1.69 (m, 2H, CH2); 3.47-3.48 (m, 2H, CH2); 5.10 (s, 2H, CH2); 6.38-6.40 (m, 1H, ArH); 7.45-7.50

(m, 3H, ArH); 7.62-7.66 (m, 1H, ArH); 7.74 (d, 1H, ArH, J=8,4 Hz); 7.72-7.75 (m, 1H, ArH); 7.96 (s, 1H, ArH); 8.15-8.16 (m, 1H, ArH); 8.35 (t, 1H, NH, exch D20, J=5,4 Hz); 8.43 (d, 1H, ArH, J=9,2 Hz); 8.52 (d, 1H, ArH, J=8 Hz); 9.51-9.55 (m, 1H, NH, exch D2O). N1 -((6-(4-nitrobenzo[c][1,2,5]oxadiazol-7-ylamino)hexylcarbamoyl)methyl)-3-phenyl[1,2,4]Triazino[4,3-a]benzimidazol-[4(10H)-one] 78. Yield: 49%; 1H-NMR (DMSO-d6, ppm): 1.19 (s, 2H, CH2); 1.31-1.37 (m, 2H, CH2); 1.41-1.53 (m, 2H, CH2); 1.62-1.67 (m, 2H, CH2); 3.10-3.15 (m, 2H, CH2); 3.42-3.44 (m,2H, CH2); 5.10 (s, 2H, CH2); 6.34 (d, 1H, ArH, J=8,4Hz); 7.43-7.49 (m, 4H, ArH);

7.64-7.67 (m, 1H, ArH); 7.73 (d, 1H, ArH, J=8Hz); 8.16 (d, 2H, ArH, J=6,8Hz); 8.30 (t, 1H, NH, exch D2O; J=7,8Hz); 8.44 (d, 1H, ArH, J=8,8Hz);

Riferimenti

Documenti correlati

Finally, we propose the trace-based semantics, which exploits the interval structures induced by the infinite paths of the Kripke structure.. I Definition 9 (Interval structure

Tali indicatori possono costituire i drivers per la costruzione degli scenari di evoluzione spaziale e temporale della salinizzazione dei suoli nel territorio

- Infine, già nell’approccio Lean Manufacturing trova spazio il Concurrent Engineering, ovvero l’introduzione accelerata di nuovi prodotti, un elemento che sarà poi centrale nella

Secondo il principio di Le Chatelier, un aumento di pressione induce il sistema a spostarsi verso sinistra (verso il volume minore) e questo richiede un aumento di temperatura

[30] analysed whole blood collected from preoperative cancer patients (breast, n=83; prostate, n=30; colon, n=20; and renal cancer, n=20; and melanoma, n=10) and healthy

Nel corso di due giorni di negoziati Zhou Enlai chiese ripetutamente rassicurazioni che gli Stati Uniti non avrebbero più fatto appello in sede ONU a soluzioni quali quella delle

Event Organization: Marco Giardino, University of Torino and Irene Bollati, University of Milan IYGD-2019 - Rifugio Monte Bianco (Val Veny, Courmayeur, Italia) - Giovedì 27

L’article de Françoise Favart (« La présentation de l’objet d’art dans le guide de musée et dans la visite guidée », p. 139-157) s’intéresse à la présentation de